Marburg virus vaccines

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/40 (2006.01) A61K 39/12 (2006.01) C07K 14/08 (2006.01) C07K 14/18 (2006.01) C12N 7/00 (2006.01) C12N 7/01 (2006.01) C12N 7/04 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2336554

Using the MBGV GP, NP and virion proteins, a method and composition for use in inducing an immune response which is protective against infection with MBGV in nonhuman primates is described.

L'invention concerne l'utilisation du virus de Marburg (MBGV), d'une glycoprotéine de surface (GP), d'une nucléoprotéine (NP) et d'autres protéines de la particule virale; elle concerne également un procédé et une composition utiles pour induire une réponse immune, protégeant des primats non humains de l'infection par MBGV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Marburg virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marburg virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marburg virus vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2032866

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.